Skip to main content
. 2009 Feb 20;9:62. doi: 10.1186/1471-2407-9-62

Figure 3.

Figure 3

Relative five-year survival for breast cancer patients according to (A) localized disease (stage 1–2) or (B) metastatic disease (stage 3–4), and presence or absence of BRCA2 mutations (BRCA+/-).